Abstract: Use of parasites and extracellular vesicles obtained from the parasites for a cancer treatment is provided. The use of parasites and extracellular vesicles obtained from parasites is for using in a treatment of a cancer, and loading an active substance on exosomes by using a drug loading capacity of exosomes, and thus, by carrying a specific drug directly to target cancer cells without causing any side effect on healthy cells and to enhance a bioavailability of the specific drug, achieving a desired effect in a tumor specific target region. Particularly Leishmania infantum parasite is used as a source for the extracellular vesicles.

Abstract: An endomicroscopic device, which, in microsurgical operations, enables the deep surgical sites that cannot be seen from a certain angle to become visible. The endomicroscopic device includes a light source to illuminate the surgical site, a microscope lens for taking and magnifying an image of a tissue at the surgical site, a pair of binocular eyepieces for projecting the image to eyes of the surgeon, an endoscopic probe for displaying blind areas outside of a field of view of the at least one microscope lens from different angles in a periscopic manner, an endoscopic probe outlet, and a distal portion located at an end of the endoscopic probe. The distal portion is flexible and can be angled to be directed to different areas, and provides a second periscopic image.

Abstract: A cartilage is generated by a formulation, wherein the formulation is produced by an isolated septal cartilage exosome released by cells isolated from a septal cartilage to a medium. The objective of the isolated septal cartilage exosome is to generate the cartilage to be used in a treatment of cartilage tissue defects, such as osteoarthritis or arthrosis, since the cartilage induces a cartilage formation and also suppresses an inflammatory response.

Abstract: Use of nano-sized lanthanide borate (erbium borate and dysprosium borate) compounds for wound treatment due to their significant level of wound healing effect on the cells is disclosed. In the scope of the invention, the synthesis of nanometer-sized erbium borate and dysprosium borate compound by buffered-precipitation method at room conditions and the use of these compounds in biological applications are discussed.

Abstract: Use of nano-sized lead borate compounds for treatment purposes due to their selective anticancer activity on p53 mutant breast cancer cell line, T47D is disclosed. The method of synthesizing nano-sized lead borates of the present invention comprises the steps of preparing a borate buffer solution by sodium hydroxide and boric acid, dissolving lead nitrate (and preferably PEG) in distilled water by stirring, mixing the borate buffer solution with the lead nitrate (and preferably PEG) solution, washing the resulting solution with distilled water and drying to remove the impurities.

Abstract: A medicine developed for treatment of psoriasis and production method thereof are disclosed. This medicine for treatment of psoriasis developed in the scope of the present invention comprises tallow, larch resin, beeswax, gum mastic, propolis, Alkanna tinctoria, alum and Juniper tar. The production method of the psoriasis medicine of the present invention includes the steps of: Melting the tallow at 300° C. by continuously mixing it with the beeswax, adding first the gum mastica and then the propolis to the obtained molten mixture, adding ground larch resin to the mixture together with alum, finally adding ground Alkanna tinctoria and juniper tar to the mixture, obtaining a homogenous mixture by means of continuous mixing, filtering the homogenous mixture, obtaining the medicine for treatment of psoriasis, which is the final product in the form an elute.

Abstract: Use of the effects of plant exosomes on the immune system as immune system enhancers, silencers and modulators against diseases is disclosed. The plant derived exosomes are obtained from at least one portion of the plant selected from the group consisting of the entire plant, fruit, leaf, seed, root, or differentiated tissues like the plant's tissue culture medium, stem cell, waste material, shell or phloem. In the scope of the invention, the plant exosomes having immunomodulatory effects are used mainly in autoimmune diseases, and in cell, tissue, organ transplantations and in Graft Versus Host disease as immune system enhancers, suppressors or, if necessary, as modulators performing both of the first two functions.

Abstract: The present invention relates to surfaces which are featured with antimicrobial property. Combinations made with zinc pyrithione, chlorhexidine gluconate and/or triclosan are used in the invention. The invention enables to prevent biodegradation or biocontamination occurring on surfaces. In sectors where surface coating materials are widely used, the pathogen factors (bacteria, yeasts and fungi), which are the causes of surface-borne hygiene, allergy and infectious diseases, are controlled.

Abstract: The present invention relates to a gelatin or pectin based antimicrobial surface coating material. In the present invention, boron compounds are mixed with gelatin or pectin and a surface coating material in the form of a film is obtained. The said coating material can be used in all packaging industry requiring hygiene particularly in food industry. The invention enables packages to be antifungal, anticandidal and antibacterial.

Abstract: An antimicrobial (anticandidal, antibacterial, antifungal) and antiviral composition which repels insects such as flies, mosquitoes and ticks. The composition includes poloxamer, boron compound, ethyl butyl acetylaminopropionate and preferably hydrogen peroxide. The present composition is a composition which can be applied in different forms via oral, nasal, ophthalmic, otic, local, ventricle, vaginal, rectal, dermal, intravenous, intramuscular, subcutaneous and intradermal route.

Abstract: An external fixator includes at least four half rings having ledged areas on each end providing connections to form full rings, each half ring includes rod holes provided at intervals parallel to the axis of the ring and channel slots between the rod holes and the outer edge of the ring; at least four connectors to fix the half rings to each other through the connection holes; at least three threaded rods having same diameter as that of the rod holes and fit into the rod holes; nuts which fix the rods to the half rings; at least one Kirschner wire to fix the bones and soft tissues; at least two wire fixation bolts passing through the rod holes to fix the Kirschner wire at both ends to the half rings.

Abstract: A funnel control device is fixed on a shear box or respective cells in various soil mechanics/dynamics testing devices, and the funnel control device enables to produce soil samples to be tested by discharging a soil through a funnel into a sample preparation mold at a given axis and rate. The funnel control device includes at least one supporting body for being placed on the soil mechanics/dynamics testing device, at least one holder, wherein the at least one holder is provided on the at least one supporting body to be movable in vertical axis and the funnel is placed on the at least one holder, at least one driving member, wherein the at least one driving member is located in or on the at least one supporting body and is used for moving the at least one holder in the vertical axis.

Abstract: A surgical pad having a head part including an intermediate layer including an X-ray detectable material for use in surgical operations, particularly in brain and spinal cord operations. In the surgical pad, the intermediate layer is provided between layers, which are produced from 100% cotton and have a geometric shape that is manually formed.

Abstract: A computer-implemented method, which enables the data to be clustered without being required to perform any distance calculations among the points of the dataset, includes assigning points of a dataset to cells of a cellular automaton; assigning each cell, having a data point assigned, a distinct state value and a constant temperature value; and assigning all cells, to which a data point is not assigned, a unique state value different from the state values utilized for cells having a data point and to a temperature lower than the constant temperature value; selecting a cell in the cellular automaton randomly; calculating the average temperature of the selected cell and its neighbor cells; setting the temperature of the cells having no data point, as the average temperature; if a neighbor cell temperature is above the predetermined threshold value, moving this neighbor cell to the state of the selected cell.

Abstract: The present invention is an exosome isolation method for obtaining high purity exosomes inexpensively from samples of large and small amounts and types of samples from which exosomes could not be obtained before such as plant lysates. The exosome isolation method incorporates a two phase fluid extraction system, and includes the steps of isolation using dextran and PEG for removing proteins and undesired substances therein, and the steps of washing and dextran removal to collect exosomes in a pure form.

Abstract: The present invention provides a preparation method for a DNA origami based carrier, which essentially comprises the steps of performing multi-functional DNA origami based nanocarrier preparation.

Abstract: A chemotherapeutic drug composition, prepared by combination of Everolimus, one of the drugs used in the treatment of the metastatic renal cell carcinoma (RCC) comprising 2-3% of the malignant tumors, with the anti-apoptotic Bcl-2 inhibitor ABT-737 for the treatment of RCC tumors that developed drug resistance. The effect of Everolimus and ABT-737 drug composition on cell survival and cell death in Everolimus-resistant RCC cell lines overexpressing Bcl-2 protein was shown by in vitro and in vivo experiments and the mechanism of the effect of the drug composition on RCC has been examined from a molecular point of view. Navitoclax (ABT-263), an orally available analog of ABT-737, and other Bcl-2 inhibitors alone or in combination with Everolimus, which is administered once a day at a dose of 10 mg, for the use in the treatment of Everolimus-resistant RCC.

Abstract: A production of a drug, wherein the drug is specific for SH-SY5Y neuroblastoma cancer by loading caffeic acid phenethyl ester (CAPE) to a plurality of microvesicles that a specialized skin cell leaves into a nutrient solution. The objective of the present invention is to provide a cell-specific targeted vesicle development by loading the CAPE to the plurality of microvesicles obtained as a result of culturing and subsequent specialization of a plurality of tissue cells; and to use the CAPE at lower concentrations compared to a state of the art applications to minimize a toxicity of the CAPE to both a plurality of cells other than a plurality of targeted cells and a body.

Abstract: The present invention relates to a chemotherapeutic agent comprising a combination of alexidine dihydrochloride and sodium pentaborate pentahydrate. The chemotherapeutic agent includes 2.9 mg alexidine dihydrochloride compound and 2.5 mg sodium pentaborate pentahydrate compound, and is obtained by adding 0.5 ml dimethylsulfoxide compound into the alexidine dihydrochloride compound. Upon injecting them to the media containing healthy cells and cancer cells, their effects on cell viability were observed. In accordance with the obtained results; it was observed that when alexidine dihydrochloride solution at concentrations not harming healthy cells is combined with sodium pentaborate pentahydrate, pancreatic cancer cell viability decreased 10% more compared to use of alexidine dihydrochloride alone, and it was realized that this combination can be used as a chemotherapeutic agent for treatment of pancreatic cancer.

Abstract: A product containing plant derived exosome that may be used in cancer treatment and wound healing. The product enables to provide a low-cost product, which does not cause toxic effects in human body, does not cause damage in the healthy cells during the course of the cancer treatment, does not pose any infection risk since it does not require any procedure such as radiotherapy or surgery, and the side effects occurring in chemotherapy treatment are not experienced. Wheatgrass, garlic and ginger can be used alone or in combination in the product as the plant source.